AZD2171 and Pemetrexed Disodium in Treating Patients With Relapsed Non-Small Cell Lung Cancer
Status:
Completed
Trial end date:
2014-03-01
Target enrollment:
Participant gender:
Summary
This phase II trial is studying how well giving AZD2171 together with pemetrexed disodium
works in treating patients with relapsed non-small cell lung cancer. AZD2171 and pemetrexed
disodium may stop the growth of tumor cells by blocking some of the enzymes needed for cell
growth. AZD2171 may also stop the growth of tumor cells by blocking blood flow to the tumor.
Giving AZD2171 together with pemetrexed disodium may kill more tumor cells.